Allergan (AGN) Initiates Qtr. Dividend at 70c/Share; Approves $10B to Stock Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- CoreWeave stock drops on insider selling notice
Allergan (AGN) Misses Q3 EPS Views; Offers Pipeline, FY16 Guidance Updates
November 2, 2016 6:37 AM EDTAllergan (NYSE: AGN) reported Q3 EPS of $3.32, $0.26 worse than the analyst estimate of $3.58. Revenue for the quarter came in at $3.62 billion versus the consensus estimate of $3.69 billion.
New Dividend and Stock Buyback:
Allergan (NYSE: AGN) initiated a quarterly dividend of $0.70 per share, or $2.8 annualized. Yield is currently 1.3 percent.
Allergan also entered into a variable tenor accelerated share repurchase program (ASR) under which the Company will repurchase $10 billion of its ordinary shares.
Pipeline Update
Allergan R&D continued to build and deliver on... More



